Novo Holdings Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
133
- Investments
-
622
- Portfolio
-
169
- Exits
-
239
Novo Holdings General Information
Company Description
Founded in 1999, Novo Holdings is a venture arm of Novo Nordisk Foundation based in Hellerup, Denmark. The firm seeks to invest in life science companies at all stages of development across North America, Europe, and Asia. The firm also manages a portfolio of equities, bonds, real estate, and infrastructure assets.
Business Details
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- Tuborg Havnevej 19
- 2900
- 2900 Hellerup
- Denmark
Novo Holdings Investments & Acquisitions (622)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Glycomine | 16-Apr-2025 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| HepaRegenix | 15-Apr-2025 | Drug Discovery | Generating Revenue | |||
| Sparrow Quantum | 10-Apr-2025 | Application Specific Semiconductors | Generating Revenue | |||
| Sylvan (Cultivation) | 02-Apr-2025 | Cultivation | Generating Revenue | |||
| Benchmark Genetics | 31-Mar-2025 | Aquaculture | Generating Revenue | |||
| Tribune Therapeutics | 26-Mar-2025 | Drug Discovery | Generating Revenue | |||
| Hillstar Bio | 25-Mar-2025 | Drug Discovery | Pre-Clinical Trials | |||
| Supira Medical | 25-Mar-2025 | Therapeutic Devices | Generating Revenue | |||
| Augustine Therapeutics | 24-Mar-2025 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| OptiNose | 19-Mar-2025 | Buyout/LBO | Drug Delivery | Generating Revenue/Not Profitable |
Novo Holdings Exits (239)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Anthos Therapeutics | 03-Apr-2025 | Merger/Acquisition | |
| Edgewise Therapeutics | 03-Apr-2025 | ||
| Deep 6 AI | 07-Mar-2025 | ||
| BIOMILQ | 31-Jan-2025 | ||
| Prothelia | 19-Jan-2025 | ||
| PanOptica | 31-Dec-2024 | ||
| Reneo Pharmaceuticals | 04-Oct-2024 | ||
| Aerbio | 28-Aug-2024 | ||
| Invetx | 18-Jul-2024 | Buyout/LBO | |
| Amolyt Pharma | 15-Jul-2024 | Merger/Acquisition |
Novo Holdings Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Novo Holdings Co-Investors (546)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| RA Capital Management | 12 |
|
|
||
| OrbiMed |
|
|
|||
| Denmark's Export and Investment Fund |
|
|
|||
| Sofinnova Partners |
|
|
|||
| Frazier Healthcare Partners |
|
|
News about Novo Holdings
Dive into recent articles by PitchBook offering invaluable insights and context.
Novo Holdings Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| REPAIR Impact Fund | Hellerup, Denmark | 2018 |
Novo Holdings FAQs
-
What is Novo Holdings?
Founded in 1999, Novo Holdings is a venture arm of Novo Nordisk Foundation based in Hellerup, Denmark.
-
When was Novo Holdings founded?
Novo Holdings was founded in 1999.
-
Where is Novo Holdings headquartered?
Novo Holdings is headquartered in Hellerup, Denmark.
-
What is Novo Holdings's total asset value?
Novo Holdings has around in total assets under management.
-
How many investments has Novo Holdings made?
Novo Holdings has made 622 investments.
-
What has Novo Holdings invested in?
Novo Holdings has made numerous investments in companies like Glycomine, HepaRegenix, and Sparrow Quantum within the Drug Discovery and Application Specific Semiconductors industries.
-
What has Novo Holdings invested in recently?
Novo Holdings's latest investment was on 16-Apr-2025 in Glycomine, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
